Evidence map›Paper›PMID 39117608›Full record

ArticleNature communications2024

Two-dimensional single-crystalline mesoporous high-entropy oxide nanoplates for efficient electrochemical biomass upgrading.

Yanzhi Wang, Hangjuan He, Hao Lv, Fengrui Jia, Ben Liu

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yanzhi WangKey Laboratory of Green Chemistry and Technology of Ministry of Education, College of Chemistry, Sichuan University, 610064, Chengdu, China.
Hangjuan HeKey Laboratory of Green Chemistry and Technology of Ministry of Education, College of Chemistry, Sichuan University, 610064, Chengdu, China.
Hao LvKey Laboratory of Green Chemistry and Technology of Ministry of Education, College of Chemistry, Sichuan University, 610064, Chengdu, China.
Fengrui JiaKey Laboratory of Green Chemistry and Technology of Ministry of Education, College of Chemistry, Sichuan University, 610064, Chengdu, China.
Ben LiuKey Laboratory of Green Chemistry and Technology of Ministry of Education, College of Chemistry, Sichuan University, 610064, Chengdu, China. ben.liu@scu.edu.cn.ORCID http://orcid.org/0000-0003-1305-5900

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesoporous single crystals have received more attention than ever in catalysis-related applications due to their unique structural functions. Despite great efforts, their progress in engineering crystallinity and composition has been remarkably slower than expected. In this manuscript, a template-free strategy is developed to prepare two-dimensional high-entropy oxide (HEO) nanoplates with single-crystallinity and penetrated mesoporosity, which further ensures precise control over high-entropy compositions and crystalline phases. Single-crystalline mesoporous HEOs (SC-MHEOs) disclose high electrocatalytic performance in 5-hydroxymethylfurfural oxidation reaction (HMFOR) for efficient biomass upgrading, with remarkable HMF conversion of 99.3% and superior 2,5-furandicarboxylic acid (FDCA) selectivity of 97.7%. Moreover, with nitrate reduction as coupling cathode reaction, SC-MHEO realizes concurrent electrosynthesis of value-added FDCA and ammonia in the two-electrode cell. Our study provides a powerful paradigm for producing a library of novel mesoporous single crystals for important catalysis-related applications, especially in the two-electrode cell.

Identifiers

PMID39117608
PMCPMC11310307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.